Vaxcyte, Inc.

NASDAQ:PCVX

116.54 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -128.703-95.02-180.801-92.664-68.339-60.462-78.05-57.917-48.532-38.986-28.563-26.615-23.679-21.22-20.737-21.018-20.32-27.142-14.621-11.317-10.665-13.671
Depreciation & Amortization 3.4783.0912.9482.482.4012.3422.32.3542.1732.3691.2060.8560.8680.5270.3320.3340.3550.3840.3320.3040.3020.294
Deferred Income Tax 00-12.7650000000000000000.012-0.002-0.006-0.003
Stock Based Compensation 21.55817.62913.34813.2212.5449.6487.0096.6485.8944.0993.1582.9372.7691.8651.9351.8381.2890.3720.3750.2650.2790.266
Change In Working Capital -7.793-73.83338.06433.9882.4966.772-3.310.6051.0384.394-27.455-6.054-8.9685.4727.75.7759.22112.5740.1732.136-1.9733.572
Accounts Receivables 000000000000000.72300-0.7230002.603
Change In Inventory 00000000000000-10.5860014.087000-0.733
Change In Accounts Payables -10.7085.6726.4790.6942.2631.7893.471-1.3542.712-1.933-18.0711.4981.9182.18518.7728.129-0.076-0.7232.058-0.871-2.9222.603
Other Working Capital 2.915-7.96831.58533.2940.2334.983-6.77111.959-1.6746.327-9.384-7.552-10.8863.287-1.209-2.3549.297-0.067-1.8853.0070.949-0.901
Other Non Cash Items 29.2887.14810.396-14.572-11.844-5.996.82-0.2380.3010.4220.5610.4610.330.1510.0020.0160.2830.179-0.677-0.844-1.45-0.226
Operating Cash Flow -121.394-159.124-128.81-57.548-62.742-47.69-65.221-38.548-39.126-27.702-51.093-28.415-28.68-13.205-10.768-13.055-9.172-13.633-14.406-9.458-13.513-9.768
Investing Activities:
Investments In Property Plant And Equipment -45.374-12.072-57.069-7.3392.14-5.609-1.147-0.843-0.938-2.92-1.382-1.719-2.208-1.246-0.722-0.029-0.055-0.349-0.953-0.06-0.166-0.016
Acquisitions Net 00-0.043-0.030.3360.4420.035-0.036-0.0270.0070.02600000000000
Purchases Of Investments -350.649-687.697-203.61-209.673-432.834-483.779-71.285-17.591-6.897-6.972-41.062-66.748-56.386-172.14500000000
Sales Maturities Of Investments 309.223248.696246.753239.29297.1341.28736.4853.143459.55142.549.99838.064000000000
Other Investing Activites 6.394-6.3940.0430.03-0.336-0.442-0.0350.0360.0270.0070.026-16.7538.064-172.14500.05000000
Investing Cash Flow -80.406-451.073-13.92622.28-333.564-448.101-35.95234.70626.16549.6660.082-18.469-20.53-173.391-0.7220.021-0.055-0.349-0.953-0.06-0.166-0.016
Financing Activities:
Debt Repayment 00000000000000-0.0610-0.001-0.06-0.058-0.065-0.079-0.076
Common Stock Issued 110.933816.4783.06549545.27941.787653.61843.12149.004110.7378.7547.5990.9560.4870.6350000000
Common Stock Repurchased -0.565-3.3063.546-2.605-0.214-0.7271.033-0.861000.8880000.3740000000
Dividends Paid 00000000000000-0.3130000000
Other Financing Activities -0.565-3.306-3.8762.1551.9010.5021.9821.7570.8740.2828.7547.5990.9560.487-0.080.036264.483109.85741.410.4330.0020
Financing Cash Flow 110.368818.1962.73548.55546.96641.562656.63344.01749.878111.0198.7547.5990.9560.4870.5550.036264.482109.79741.3520.368-0.077-0.076
Other Information:
Effect Of Forex Changes On Cash -1.416.062-7.6821.051-0.0780.0230.7960.053-0.485-0.227-0.8020.3330.311-0.2810.087000-0.341000
Net Change In Cash -92.842214.061-147.68314.333150.582-454.206556.25640.22836.432132.756-43.059-38.952-47.943-186.39-10.848-12.998255.25595.81525.652-9.15-13.756-9.86
Cash At End Of Period 518.67612.615397.451546.237531.904381.322835.528279.272239.044202.61269.856112.915151.867199.81386.2397.048410.046154.79158.97633.32442.47456.23